Literature DB >> 21030458

Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus.

Sung Rae Kim1, Ji Han Yoo, Ho Cheol Song, Seong Su Lee, Soon Jib Yoo, Young-Du Kim, Yeon Soo Lim, Hyung Wook Kim, Chul Woo Yang, Yong-Soo Kim, Euy Jin Choi, Yong Kyun Kim.   

Abstract

BACKGROUND: Obesity and diabetes mellitus (DM) are established risk factors for the development of chronic kidney disease. Visceral adiposity (VAT) and subcutaneous adiposity (SAT) may be associated with the differential metabolic risk. Our study was performed to determine whether VAT or SAT was associated with the decrease of renal function in people with type 2 DM.
METHODS: Nine hundred and twenty-nine people with type 2 DM and who had undergone abdominal computed tomography assessment of the SAT and VAT areas were included. The estimated glomerular filtration rate (eGFR) was calculated using the Cockcroft-Gault equation and the Modification of Diet in Renal Disease (MDRD) four-variable equation at the time of the assessment of the SAT and VAT areas.
RESULTS: VAT was negatively associated with eGFR using the MDRD equation after adjustment for the clinical variables (β-coefficient = - 0.075, P = 0.034), while SAT was not significantly associated with eGFR. There was no significant association between the abdominal adiposity measurements and the eGFR using the Cockcroft-Gault formula. When stratifying the individuals by the body mass index groups, VAT was negatively associated with eGFR by the MDRD equation and the Cockcroft-Gault formula in the overweight and obese subjects after adjustment for the clinical variables, while there was no significant association between the VAT and the eGFR in the normal weight subjects. SAT was not significantly associated with eGFR in the normal weight, overweight and obese subjects.
CONCLUSIONS: Our data suggest that VAT may be an additional prognostic factor for the decrease of renal function especially in the overweight or obese subjects with type 2 DM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030458     DOI: 10.1093/ndt/gfq634

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Sagittal abdominal diameter and Framingham risk score in non-dialysis chronic kidney disease patients.

Authors:  Hua Xiao; Yu Bao; Ming-Yue Liu; Jun-Hua Yang; Yan-Ting Li; Yi-An Wang; Ying Wang; Yue Yan; Zhu Zhu; Mei Ni; Xiao-Yan Huang; Xin-Kui Tian; Tao Wang; Xing-Wei Zhe
Journal:  Int Urol Nephrol       Date:  2018-04-12       Impact factor: 2.370

2.  Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study.

Authors:  Jun Huang; Chaomin Zhou; Yongqiang Li; Shuangshuang Zhu; Aiqun Liu; Xiaofei Shao; Xinyu Liu; Harry Holthfer; Hequn Zou
Journal:  Int Urol Nephrol       Date:  2015-07-07       Impact factor: 2.370

3.  Predictive performance of lipid accumulation product and visceral adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up.

Authors:  Pouria Mousapour; Maryam Barzin; Majid Valizadeh; Maryam Mahdavi; Fereidoun Azizi; Farhad Hosseinpanah
Journal:  Clin Exp Nephrol       Date:  2019-11-16       Impact factor: 2.801

4.  The association between body composition and cystatin C in South Asians: results from the MASALA study.

Authors:  Arti D Shah; Heidi Schmidt; Saunak Sen; Michael G Shlipak; Alka M Kanaya
Journal:  Obes Res Clin Pract       Date:  2014-11-18       Impact factor: 2.288

5.  Quantification of abdominal fat from computed tomography using deep learning and its association with electronic health records in an academic biobank.

Authors:  Matthew T MacLean; Qasim Jehangir; Marijana Vujkovic; Yi-An Ko; Harold Litt; Arijitt Borthakur; Hersh Sagreiya; Mark Rosen; David A Mankoff; Mitchell D Schnall; Haochang Shou; Julio Chirinos; Scott M Damrauer; Drew A Torigian; Rotonya Carr; Daniel J Rader; Walter R Witschey
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

6.  Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Authors:  Francis Agyemang-Yeboah; Benjamin Ackon Jnr Eghan; Max Efui Annani-Akollor; Eliezer Togbe; Sampson Donkor; Bright Oppong Afranie
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

7.  Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population.

Authors:  Tong Chen; Xuan Wang; Xin Wang; Haishan Chen; Hua Xiao; Hongjuan Tang; Ling Feng; Zhicong Xiang; Hequn Zou; Xiaofei Shao
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-10       Impact factor: 3.168

8.  Association of Visceral Fat Area and Hyperuricemia in Non-Obese US Adults: A Cross-Sectional Study.

Authors:  Zhiying Li; Lijie Gao; Xiaoqing Zhong; Guanrui Feng; Fengqiu Huang; Sujian Xia
Journal:  Nutrients       Date:  2022-09-26       Impact factor: 6.706

9.  Estimated visceral adipose tissue, but not body mass index, is associated with reductions in glomerular filtration rate based on cystatin C in the early stages of chronic kidney disease.

Authors:  Ana Karina Teixeira da Cunha França; Alcione Miranda Dos Santos; João Victor Salgado; Elane Viana Hortegal; Antônio Augusto Moura da Silva; Natalino Salgado Filho
Journal:  Int J Nephrol       Date:  2014-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.